Drug repurposing for the treatment of COVID-19

• Hoofdauteurs: Yuri Kato (Auteur), Kazuhiro Nishiyama (Auteur), Akiyuki Nishimura (Auteur), Takamasa Noda (Auteur), Kaori Okabe (Auteur), Takahiro Kusakabe (Auteur), Yasunari Kanda (Auteur), Motohiro Nishida (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2022-07-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Coronavirus disease 2019 (COVID-19) remains prevalent worldwide since its onset was confirmed in Wuhan, China in 2019. Vaccines against the causative virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have shown a preventive effect against the onset and severity of COVID-19, and so...